The state of dry, wet AMD in 2021

Video

Rishi P. Singh, MD, highlights various treatment options available for the management of patients with age-related macular degeneration, as well as the status of potential therapies.

See more AMD content here

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Subscribe Now!
Recent Videos
Abby Markward and Hattie Hayes discuss the ASCRS Annual Meeting, the ASOA Annual Meeting, and the Retina Day event.
Related Content
FDA issues CRL for Regeneron's aflibercept 8 mg (Eylea HD) sBLA

FDA issues CRL for Regeneron's aflibercept 8 mg (Eylea HD) sBLA

Martin David Harp;Hattie Hayes;Kassi Filkins
April 21st 2025
Article
John Kitchens, MD, is joined by Peter Kaiser, MD, to discuss higher molar dose and its translation into clinical practice

Implementing Higher Molar Dose in Your Clinical Practice

John Kitchens, MD;Peter K. Kaiser, MD
July 24th 2024
Podcast
Aflibercept: Applications for dosing duration and additional indications pending decision with FDA and EMA

Aflibercept: Applications for dosing duration and additional indications pending decision with FDA and EMA

Sydney M Crago
April 16th 2025
Article
Biocon, Regeneron settle to launch aflibercept biosimilar, Yesafili in the US

Biocon, Regeneron settle to launch aflibercept biosimilar, Yesafili in the US

Martin David Harp
April 15th 2025
Article
New guidelines boost choriocapillaris imaging in AMD with SS-OCTA

New guidelines boost choriocapillaris imaging in AMD with SS-OCTA

Alessandro Berni, MD;Philip J. Rosenfeld, MD, PhD
April 14th 2025
Article
FDA accepts Outlook Therapeutics' updated biologics license application for ONS-5010 to treat wet AMD

FDA accepts Outlook Therapeutics' updated biologics license application for ONS-5010 to treat wet AMD

Martin David Harp
April 9th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.